Reperfusion Therapy for Acute Myocardial Infarction

Demonstrating the benefits of reperfusion therapy, this volume examines fibrinolytic agents that can be used alone or in combination with other care regimens to improve the benefits of reperfusion therapy and reduce the risks of treatment. It summarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapy, helping specialists identify barriers to the early treatment of patients in various practice environments. The book also reviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy.